EMIT II Plus Methaqualone Assay
The EMIT® II Plus Methaqualone Assay is intended for the qualitative and semiquantitative analysis of methaqualone in human urine at a cutoff level of 300 ng/mL.
EMIT II Plus Methaqualone Assay
Detect methaqualone, methaqualone metabolites, and mecloqualone
Features & Benefits
Methaqualone is a sedative-hypnotic drug that is usually taken orally. This was once a prescribed treatment for insomnia and anxiety and is now a highly addictive and Schedule I controlled illegal substance. The EMIT II Plus Methaqualone Assay detects methaqualone and methaqualone metabolites, and also the pharmaceutically similar drug mecloqualone.
The EMIT II Plus Methaqualone Assay provides:
- Good specificity for methaqualone and metabolites
- Excellent precision—all within-lab (total) CVs ≤0.7% or less across the assay range
- Ready-to-use liquid reagents, calibrators, and controls
- 98% correlation to reference method (GC/MS)
Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems; AU® Series analyzers; Dimension® Integrated Chemistry Systems; and Dimension Vista® Intelligent Lab Systems.
Technical Specifications
EMIT II Plus Ethyl Methaqualone Performance
Assay Principle | Homogeneous Enzyme Multiplied Immonoassay (EMIT) |
Cut-off | 300 ng/mL |
Sample | Urine |
Reagent Stability | Unopened: until expiration date. Onboard instrument: up to 4 weeks |
Calibration Frequency | As indicated by control results |